InPlay from Briefing.com22 Jul 2014, 4:53 pmInPlay from Briefing.com
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film22 Jul 2014, 5:05 amPORTLAND, Ore. -- Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, ...
( NewsUSA20 Jul 2014, 8:50 pm) - You may not be able to spell or even pronounce the word "acetaminophen," but almost 50 million Americans use it each week to manage pain and fever.
Can Health Care's Redbox Make Pharmacies Obsolete?19 Jul 2014, 12:23 amA Redbox for prescription drugs? The next Rx revolution could be on the way thanks to this disruptive new technology.
Your fitPrescription for sustained weight loss16 Jul 2014, 7:34 amLosing weight is extremely difficult but maintaining that weight loss is next to impossible unless you set yourself up for success.
PRESS RELEASE: WILEX AG publishes Half-yearly -2-15 Jul 2014, 12:11 am
PRESS RELEASE: WILEX AG publishes Half-yearly Financial Report 201415 Jul 2014, 12:11 am
DGAP-News: WILEX AG publishes Half-yearly Financial Report 201414 Jul 2014, 11:36 pm
Collaborations, Critical Takeover Decisions, Quarterly Dividends, and Litigation Settlements - Analyst Notes on ...30 Jun 2014, 5:58 amNEW YORK, June 30, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Bristol-Myers Squibb Company (NYSE: BMY), Allergan Inc. (NYSE: AGN), CR Bard Inc. (NYSE: BCR), Perrigo Co. (NYSE: PRGO) and Health Net, Inc. (NYSE: HNT). Private wealth members receive...
Perrigo Settles Patent Dispute with Teva - Analyst Blog23 Jun 2014, 11:25 amPerrigo Settles Patent Dispute with Teva - Analyst Blog